NCT04369963

Brief Summary

Researchers at Seattle Children's Research Institute want to find ways to understand gastrointestinal disease such as Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS) and Graft-Versus-Host-Disease (GVHD). We want to compare healthy cells from the gastrointestinal tract to cells from people with gastrointestinal diseases. The investigators are looking for healthy participants 18-25 with no gastrointestinal symptoms to volunteer to have an upper and lower endoscopy and to collect blood and stool samples. The investigators hope the information gathered in this study will help to better predict and treat these diseases in the future. Participants who join the study will complete the following activities: 1 hour appointment at Seattle Children's Hospital to determine eligibility Blood Draw Upper and Lower Endoscopy with tissue biopsies Stool Sample collection Participants will get $600 to thank them for their time. Participants may be eligible for this study if they meet the following requirements: 18 -25 years of age Do not have any abdominal symptoms (vomiting, diarrhea or abdominal pain) Are not on any medications (vitamins and birth control are OK) Have a BMI (body mass index) between 20-25 kg/m\^2 Please note: Interested participants will have a 30 minute phone call with the study team and subsequent 1 hour appointment at Seattle Children's to determine if they meet all of the eligibility criteria.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 14, 2019

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 28, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 30, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2022

Completed
Last Updated

April 17, 2024

Status Verified

April 1, 2024

Enrollment Period

2.3 years

First QC Date

April 28, 2020

Last Update Submit

April 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • To create a single-cell RNA atlas of healthy gastrointestinal tract from healthy participants

    A single-cell RNA atlas of the healthy gastrointestinal tract will be created through flow cytometry, T Cell receptor deep sequencing, single cell transcriptome analysis and whole transcriptome analysis on immune cells purified from GI tissue samples and peripheral blood.

    2 years

Interventions

Participants will have an esophagogastroduodenoscopy and colonoscopy with biopsies. Biopsies from esophagogastroduodenoscopy will not exceed 16 pinch biopsies, biopsies from colonoscopy will not exceed 16 pinch biopsies. Participants will have anesthesia for both procedures.

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

You may be eligible for this study if you are: 18 -25 years of age Do not have any abdominal symptoms (vomiting, diarrhea or abdominal pain) Are not on any medications (vitamins and birth control are OK) Have a BMI (body mas index) between 20-25 Please note: Interested participants will have a 30 minute phone call with the study team and subsequent 1 hour appointment at Seattle Children's to determine if you meet all of the eligibility criteria.

You may qualify if:

  • Age 18 -25
  • BMI between 20-25
  • Participant as no signs or symptoms of present illness
  • Participant has no known chronic illness

You may not qualify if:

  • On medications other than birth control or vitamins
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seattle Children's Hospital

Seattle, Washington, 98105, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

GI tissue biopsies, stool, blood

MeSH Terms

Conditions

Inflammatory Bowel DiseasesGastrointestinal Diseases

Interventions

Endoscopy, Digestive SystemColonoscopyBiopsy

Condition Hierarchy (Ancestors)

GastroenteritisDigestive System DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresEndoscopy, GastrointestinalCytodiagnosisCytological TechniquesClinical Laboratory TechniquesSpecimen HandlingInvestigative Techniques

Study Officials

  • Betty Zheng, MD

    Seattle Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Week
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 28, 2020

First Posted

April 30, 2020

Study Start

March 14, 2019

Primary Completion

July 1, 2021

Study Completion

February 5, 2022

Last Updated

April 17, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will share

Collaborators in Leslie Kean's lab at Boston Children's Hospital will have access to coded data and specimens. Data and specimens that may be shared include: GI tissue samples, whole blood, urine, stool, cDNA, and clinical data without identifying information.

Time Frame
Data and specimens will be stored indefinitely and may be shared at any point in the study's duration
Access Criteria
Study team members at Seattle Children's will have access to patient records and specimens with identification. Collaborator's at Boston Children's will have access to coded specimens and data at request

Locations